- Title
- Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
- Creators - without role
- Khadega A Abuelgasim - King Abdullah International Medical Research CenterMohsen Alzahrani - King Abdullah International Medical Research CenterYousef Alsharhan - King Saud bin Abdulaziz University for Health SciencesMoataz Khairi - King Saud bin Abdulaziz University for Health SciencesMohammed Hommady - King Saud bin Abdulaziz University for Health SciencesGiamal Gmati - King Abdulaziz Medical CityHind Salama - King Abdulaziz Medical CityOsama Ali - King Abdulaziz Medical CityBader Alahmari - King Abdulaziz Medical CityEmad M Masuadi - King Saud bin Abdulaziz University for Health SciencesAhmed Alaskar - King Abdulaziz Medical CityAyman Alhejazi - King Abdulaziz Medical CityMoussab Damlaj - King Abdulaziz Medical City
- Publication Details
- Bone marrow transplantation (Basingstoke), Vol.54(7), pp.1168-1172
- Identifiers
- 9920776408331
- Academic Unit
- King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz University
- Language
- English
- Resource Type
- Journal article
Journal article
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
Bone marrow transplantation (Basingstoke), Vol.54(7), pp.1168-1172
01/07/2019
PMCID: PMC6760548
PMID: 30700792
Metrics
1 Record Views